Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
Cyclin Dependent Kinase Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Kisqali
(ribociclib) / Novartis
AiRuiKang
(dalpiciclib) / Jiangsu Hengrui Pharma
alvocidib
(DSP-2033) / Sumitomo Pharma
TQB3616
/ Sino Biopharm
zotiraciclib
(TG02) / Cothera Biosci
